X-77684343-T-C
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000489.6(ATRX):c.913A>G(p.Ser305Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000828 in 1,208,254 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000489.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia-X-linked intellectual disability syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- ATR-X-related syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability-hypotonic facies syndrome, X-linked, 1Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | NM_000489.6 | MANE Select | c.913A>G | p.Ser305Gly | missense | Exon 9 of 35 | NP_000480.3 | ||
| ATRX | NM_138270.5 | c.799A>G | p.Ser267Gly | missense | Exon 8 of 34 | NP_612114.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | ENST00000373344.11 | TSL:1 MANE Select | c.913A>G | p.Ser305Gly | missense | Exon 9 of 35 | ENSP00000362441.4 | ||
| ATRX | ENST00000395603.7 | TSL:1 | c.799A>G | p.Ser267Gly | missense | Exon 8 of 34 | ENSP00000378967.3 | ||
| ATRX | ENST00000624166.3 | TSL:1 | c.796A>G | p.Ser266Gly | missense | Exon 8 of 14 | ENSP00000485103.1 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112582Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000164 AC: 3AN: 182401 AF XY: 0.0000297 show subpopulations
GnomAD4 exome AF: 0.00000639 AC: 7AN: 1095620Hom.: 0 Cov.: 32 AF XY: 0.00000831 AC XY: 3AN XY: 361106 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112634Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34792 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.913A>G (p.S305G) alteration is located in exon 9 (coding exon 9) of the ATRX gene. This alteration results from a A to G substitution at nucleotide position 913, causing the serine (S) at amino acid position 305 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Alpha thalassemia-X-linked intellectual disability syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at